KKR Swaps Jazz Pharma Board Members

Nathaniel Zilkha, a principal with Kohlberg Kravis Roberts & Co., has joined the board of KKR portfolio company Jazz Pharmaceuticals Inc. (Nasdaq: JAZZ). He replaces KKR colleague Adam Clammer. www.jazzpharmaceuticals.com